186 related articles for article (PubMed ID: 31019863)
1. Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes.
Saigal K; All S; Potrebko P; Feranec N; Keller A; Lizaso M; Warner C; Nguyen N; Jain A; Biagioli M
Cureus; 2019 Feb; 11(2):e4085. PubMed ID: 31019863
[TBL] [Abstract][Full Text] [Related]
2. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
[TBL] [Abstract][Full Text] [Related]
4. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
[TBL] [Abstract][Full Text] [Related]
5. Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer.
Buus S; Rylander S; Hokland S; Søndergaard CS; Pedersen EM; Tanderup K; Bentzen L
Brachytherapy; 2016; 15(4):426-434. PubMed ID: 27220699
[TBL] [Abstract][Full Text] [Related]
6. Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.
Kamrava M; Chung MP; Kayode O; Wang J; Marks L; Kupelian P; Steinberg M; Park SJ; Demanes DJ
Brachytherapy; 2013; 12(5):434-41. PubMed ID: 23406987
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
[TBL] [Abstract][Full Text] [Related]
8. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
10. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
11. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
[TBL] [Abstract][Full Text] [Related]
12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
13. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer.
Shahbazian H; Birgani MJT; Bagheri A; Arvandi S; Razmjoo S; Ghadamgahi P; Bakhali R; Feli M
J Contemp Brachytherapy; 2020 Apr; 12(2):201-206. PubMed ID: 32395146
[TBL] [Abstract][Full Text] [Related]
15. [Dosimetric analysis of different optimization algorithms for three-dimensional brachytherapy for gynecologic tumors].
Ling B; Chen L; Zhang J; Cao X; Ye W; Ouyang Y; Chi F; Ding Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):773-779. PubMed ID: 38708512
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
17. [Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer].
Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Major T
Magy Onkol; 2007; 51(1):31-8. PubMed ID: 17417673
[TBL] [Abstract][Full Text] [Related]
18. [Prostate cancer boost using high-dose-rate brachytherapy: impact of the learning curve on the dosimetry].
Benhaïm C; Chand MÈ; Gal J; Hijazi H; Gautier M; Hannoun-Lévi JM
Cancer Radiother; 2014 Nov; 18(7):659-65. PubMed ID: 25176296
[TBL] [Abstract][Full Text] [Related]
19. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
20. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
